A case study of an adaptive design for a clinical trial with 2 doses and 2 endpoints in a rare disease area

Pharmaceutical Statistics, EarlyView.

Source: Pharmaceutical Statistics - September 17, 2018 Category: Statistics Authors: HuiQuan , YiXu , YixinChen , LeiGao , XunChen Source Type: research